Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes-Reference-Cited by-同舟云学术

Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in Type 2 diabetes

Published:2009-06 Issue:6 Volume:26 Page:649-654
ISSN:0742-3071
Container-title:Diabetic Medicine
language:en
Short-container-title:

Author:

Cuthbertson J.,Patterson S.,O’Harte F. P. M.,Bell P. M.

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.2009.02748.x/fullpdf

Reference23 articles.

1. Insulinotropic hormone glucagon-like peptide-1 differentiation of human pancreatic islet-derived progenitor cells into insulin-producing cells;Abraham;Endocrinology,2002

2. Glucagon-like peptide-1 reduces hepatic glucose production indirectly through insulin and glucagon in humans;Larsson;Acta Physiol Scand,1997

3. Glucagon-like peptide-1 reduces postprandial glycaemic excursions in IDDM;Dupre;Diabetes,1995

4. Gastric emptying, glucose responses and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (non-insulin-dependent) diabetic patients;Willms;J Clin Endocrinol Metab,1996

5. Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study;Zander;Lancet,2002

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding the action mechanisms of metformin in the gastrointestinal tract;Frontiers in Pharmacology;2024-03-28

2. Secondary analysis of newly diagnosed type 2 diabetes subgroups and treatment responses in the MARCH cohort;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2024-01

3. DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature;Frontiers in Molecular Biosciences;2023-05-23

4. Mechanisms of Action of Metformin;Metformin - Pharmacology and Drug Interactions;2021-12-15

5. Repurposing metformin for covid-19 complications in patients with type 2 diabetes and insulin resistance;Immunopharmacology and Immunotoxicology;2021-05-04